Phenytoin-induced resistance to pancuronium.
نویسندگان
چکیده
منابع مشابه
Phenytoin-induced gingival overgrowth.
Gingival overgrowth is a common adverse effect of therapy with Phenytoin, having important medical and cosmetic implications. Poor periodontal hygiene is an important risk factor for severity of Phenytoin-induced gingival overgrowth (PIGO), which is a time-dependent process. There is complex interplay of altered fibroblast biology, connective tissue turnover, inflammatory processes, and growth ...
متن کاملPhenytoin induced status epilepticus.
T here is a growing body of literature that patients on antiepileptic drugs may experience worsening of seizure control such as increasing frequency, inducing new seizures, refractory seizures, and so forth. 1 Phenytoin is used in all types of seizure except absence seizure and is the most commonly prescribed antiepileptic drug due to its cost and availability. 2 Phenytoin is known for its side...
متن کاملPhenytoin-induced gingival enlargement.
To cite: Chacko LN, Abraham S. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2014204670 DESCRIPTION Gingival overgrowth occurs as a side effect of some systemic medications. It is now well established that phenytoin is one such agent. It has multiple therapeutic indications ranging from convulsive disorders and neuralgias to cardiac arrhythmia. The incidence rat...
متن کاملPhenytoin-Induced Rhabdomyolysis
Summary. A 53-year-old Hispanic male with a history of seizure disorder was admitted for acute kidney injury (AKI) and rhabdomyolysis due to status epilepticus. He was managed with IV fluids and IV phenytoin. No breakthrough seizures occurred on admission and AKI quickly resolved. Twenty-four hours after therapeutic levels of serum phenytoin were reached, serum creatine kinase (CK) levels peake...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Anaesthesia
سال: 1988
ISSN: 0003-2409,1365-2044
DOI: 10.1111/j.1365-2044.1988.tb05749.x